TY - JOUR AU - Coles, A J; Fox, E; Vladic, A TI - Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trial JO - Neurology VL - 78 PY - 2012 DO - 10.1212/WNL.0b013e31824e8ee7 L3 - PubMed-ID: 22442431 SP - 1069 EP - 1078 N1 - et al. ER -